These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Mahler M, Miller FW, Fritzler MJ. Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190 [Abstract] [Full Text] [Related]
4. Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series. Giannini M, Notarnicola A, Dastmalchi M, Lundberg IE, Lopalco G, Iannone F. Clin Rheumatol; 2016 Sep; 35(9):2363-7. PubMed ID: 27068736 [Abstract] [Full Text] [Related]
5. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, Cordier JF, Cottin V. Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867 [Abstract] [Full Text] [Related]
6. Myositis-related interstitial lung disease and antisynthetase syndrome. Solomon J, Swigris JJ, Brown KK. J Bras Pneumol; 2011 Sep; 37(1):100-9. PubMed ID: 21390438 [Abstract] [Full Text] [Related]
7. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF. J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208 [Abstract] [Full Text] [Related]
8. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience. Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B. Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600 [Abstract] [Full Text] [Related]
9. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies. Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K. J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479 [Abstract] [Full Text] [Related]
10. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ. Q J Med; 1990 Oct; 77(282):1019-38. PubMed ID: 2267280 [Abstract] [Full Text] [Related]
11. [The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time]. Hengstman GJ, van Venrooij WJ, van den Hoogen FH, van Engelen BG. Ned Tijdschr Geneeskd; 2003 Aug 02; 147(31):1485-9. PubMed ID: 12924076 [Abstract] [Full Text] [Related]
14. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ. Intern Med J; 2011 Sep 02; 41(9):674-9. PubMed ID: 20059602 [Abstract] [Full Text] [Related]
15. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. Targoff IN. J Immunol; 1990 Mar 01; 144(5):1737-43. PubMed ID: 2307838 [Abstract] [Full Text] [Related]
17. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O. Autoimmun Rev; 2012 Dec 01; 12(2):210-7. PubMed ID: 22771754 [Abstract] [Full Text] [Related]
18. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Targoff IN, Arnett FC. Am J Med; 1990 Mar 01; 88(3):241-51. PubMed ID: 2178410 [Abstract] [Full Text] [Related]